These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10706013)

  • 1. Extrapyramidal symptoms and oestrogen.
    Thompson KN; Kulkarni J; Sergejew AA
    Acta Psychiatr Scand; 2000 Feb; 101(2):130-4. PubMed ID: 10706013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis.
    Huber TJ; Borsutzky M; Schneider U; Emrich HM
    Acta Psychiatr Scand; 2004 Apr; 109(4):269-74. PubMed ID: 15008800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid shifts in therapeutic and extrapyramidal effects of neuroleptics.
    McEvoy JP
    Am J Psychiatry; 1986 Nov; 143(11):1504. PubMed ID: 2877588
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone in the treatment of elderly patients with psychotic disorders.
    Madhusoodanan S; Brecher M; Brenner R; Kasckow J; Kunik M; Negrón AE; Pomara N
    Am J Geriatr Psychiatry; 1999; 7(2):132-8. PubMed ID: 10322240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.
    Kamin J; Manwani S; Hughes D
    Psychiatr Serv; 2000 Mar; 51(3):287-9. PubMed ID: 10686232
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drug side effects: their relationship to dose.
    Kane JM
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic dose reduction in older psychotic patients.
    Harris MJ; Heaton RK; Schalz A; Bailey A; Patterson TL
    Schizophr Res; 1997 Oct; 27(2-3):241-8. PubMed ID: 9416653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of two novel antipsychotics in first episode non-affective psychosis: one-year outcome on symptoms, motor side effects and cognition.
    Malla A; Norman R; Scholten D; Townsend L; Manchanda R; Takhar J; Haricharan R
    Psychiatry Res; 2004 Dec; 129(2):159-69. PubMed ID: 15590043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy.
    Hriso E; Kuhn T; Masdeu JC; Grundman M
    Am J Psychiatry; 1991 Nov; 148(11):1558-61. PubMed ID: 1681751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J; Wehrli MV; Stephan PL; Agarwalla P
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal neurological signs at the onset of psychosis.
    Scheffer RE
    Schizophr Res; 2004 Sep; 70(1):19-26. PubMed ID: 15246459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history and CSF homovanillic acid pattern during neuroleptic treatment.
    Bowers MB
    Am J Psychiatry; 1984 Feb; 141(2):296-8. PubMed ID: 6140868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased extrapyramidal symptoms with addition of lithium to neuroleptics.
    Addonizio G; Roth SD; Stokes PE; Stoll PM
    J Nerv Ment Dis; 1988 Nov; 176(11):682-5. PubMed ID: 2903220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
    Farde L; Nordström AL; Wiesel FA; Pauli S; Halldin C; Sedvall G
    Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.